Exponent, Inc. (EXPO) Stock Analysis
Recovery setup
Industrials · Engineering & Construction
Hold if already holding. Not a fresh buy at $66.59, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -1.7%/30d (confirmed downtrend).
Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 55 years of experience in analyzing... Read more
Hold if already holding. Not a fresh buy at $66.59, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -1.7%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 49. Maintain position. Not compelling to add more. Score 5.7/10, moderate confidence.
Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity no date, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-04-06Item 5.02MEDIUM. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** Appointment of John D. Pye, Ph.D. On April 6, 2026, Exponent, Inc.'s (the "Company") board of directors (the "Board") appointed Dr.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
10 dimensions · all in-band
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $66.59, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -1.7%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 49. Maintain position. Not compelling to add more. Target $76.50 (+14.9%), stop $62.42 (−6.7%), A.R:R 2.4:1. Score 5.7/10, moderate confidence.
Take-profit target: $76.50 (+15.1% upside). Target $76.50 (+14.9%), stop $62.42 (−6.7%), A.R:R 2.4:1. Stop-loss: $62.42.
Below 200-MA, MA slope -1.7%/30d (confirmed downtrend).
Exponent, Inc. trades at a P/E of 32.3 (forward 24.6). TrendMatrix value score: 4.8/10. Verdict: Hold.
10 analysts cover EXPO with a consensus score of 4.1/5. Average price target: $90.
What does Exponent, Inc. do?Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90...
Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 55 years of experience in analyzing accidents and failures to advise clients as they innovate their technologically complex products and processes, ensure the safety and health of their users, and address the challenges o